The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system
Abstract
The neurotensin (NT) receptor, NTS3, originally identified as the intracellular sorting protein sortilin, is a member of a recently discovered family of receptors characterized by a single transmembrane domain. The present study provides the first comprehensive description of the distribution of NTS3/sortilin mRNA and protein in adult rat brain using in situ hybridization and immunocytochemistry. Both NTS3/sortilin mRNA and immunoreactivity displayed a widespread distribution throughout the brain. High levels of NTS3/sortilin expression and immunoreactivity were found in neuronal cell bodies and dendrites of allocortical areas such as the piriform cortex and hippocampus. Regions expressing both high levels of NTS3/sortilin mRNA and protein also included several neocortical areas, the islands of Calleja, medial and lateral septal nuclei, amygdaloid nuclei, thalamic nuclei, the supraoptic nucleus, the substantia nigra, and the Purkinje cell layer of the cerebellar cortex. In the brainstem, all cranial nerve motor nuclei were strongly labeled. NTS3/sortilin mRNA and immunoreactivity were also detected over oligodendrocytes in major fiber tracts. Subcellularly, NTS3/sortilin was predominantly concentrated over intracytoplasmic membrane‐bound organelles. Many of the areas exhibiting high levels of NTS3/sortilin (e.g., olfactory cortex, medial septum, and periaqueductal gray) have been documented to contain high concentrations of NT nerve cell bodies and axons, supporting the concept that NTS3/sortilin may play a role in NT sorting and/or signaling. Other areas (e.g., hippocampal CA fields, cerebellar cortex, and cranial nerve motor nuclei), however, are NT‐negative, suggesting that NTS3/sortilin also exerts functions unrelated to NT signaling. J. Comp. Neurol. 461:483–505, 2003. © 2003 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Expression of sortilin in the CNS is restricted to neurons.
“Because expression of sortilin in the CNS is restricted to neurons (Sarret et al., 2003), we assessed the quantitative contribution of this receptor pathway to neuronal APOE/Aβ catabolism.”
From The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain (2013) · cites this paper as Sarret et al., 2003
Sortilin and apoE3 interactions distinctly affect fatty acid metabolism in neurons but not astrocytes.
“Apparently, sortilin and apoE3 interactions distinctly affected the fatty acid metabolism in neurons, but not astrocytes, a finding in line with the predominant neuronal expression of the receptor26.”
From Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel (2025) · cites this paper as [26]
Citations
Cites
Nielsen, M. S., Madsen, P., Christensen, E. I., Nykjær, A., Gliemann, J., Kasper, D., Pohlmann, R., & Petersen, C. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2180 · Cited by 457
Self-citation
Flagged first, then by citations
Research works printed but not linked: 84
- 10.1177/40.10.1527370 · DOI
- 10.1002/(SICI)1096-9861(19981228)402:4<475::AID-CNE4>3.0.CO;2-9 · DOI
- 10.1146/annurev.pharmtox.42.091701.082314 · DOI
- 10.1097/00001756-200104170-00044 · DOI
- 10.1016/S0014-2999(97)01510-0 · DOI
- Binder EB, 2001, Neurotensin and dopamine interactions, Pharmacol Rev, 53, 453
- 10.1002/(SICI)1096-9861(19960909)373:1<76::AID-CNE7>3.0.CO;2-A · DOI
- 10.1523/JNEUROSCI.18-20-08473.1998 · DOI
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.1016/S0898-6568(01)00239-X · DOI
- 10.1523/JNEUROSCI.21-19-07598.2001 · DOI
- Cape EG, 2000, Neurotensin‐induced bursting of cholinergic basal forebrain neurons promotes gamma and theta cortical activity together with waking and paradoxical sleep, J Neurosci, 20, 8452, 10.1523/JNEUROSCI.20-22-08452.2000 · DOI
- 10.1016/S0021-9258(19)43429-7 · DOI
- 10.1016/0306-4522(90)90438-A · DOI
- 10.1016/0306-4522(92)90422-X · DOI
- Chabry J, 1993, Implication of various forms of neurotensin receptors in the mechanism of internalization of neurotensin in cerebral neurons, J Biol Chem, 268, 17138, 10.1016/S0021-9258(19)85313-9 · DOI
- 10.1002/ijc.1225 · DOI
- 10.1523/JNEUROSCI.09-07-02247.1989 · DOI
- Dournaud P, 1998, Interrelationships between somatostatin sst2A receptors and somatostatin‐containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin, J Neurosci, 18, 1056, 10.1523/JNEUROSCI.18-03-01056.1998 · DOI
- 10.1016/S0014-2999(99)00554-3 · DOI
- 10.1523/JNEUROSCI.19-01-00503.1999 · DOI
- Emson PC, 1985, GABA and neuropeptides in the CNS, Part I, 355
- 10.1016/S0028-3908(00)00060-5 · DOI
- 10.1523/JNEUROSCI.15-06-04140.1995 · DOI
- 10.1016/0306-4522(95)00145-9 · DOI
- Gully D, 1997, Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist, J Pharmacol Exp Ther, 280, 802
- 10.1007/s004390100504 · DOI
- 10.1016/S0163-7258(98)00009-6 · DOI
- 10.1016/S0925-4773(97)00177-9 · DOI
- 10.1016/S0169-328X(99)00022-4 · DOI
- 10.1016/S0167-4781(00)00044-0 · DOI
- 10.1006/bbrc.1999.1822 · DOI
- 10.1016/S0304-3940(01)02252-2 · DOI
- 10.1097/00001756-200101220-00014 · DOI
- 10.1073/pnas.83.16.6203 · DOI
- 10.1074/jbc.271.49.31379 · DOI · Paper page
- 10.1002/cne.902100302 · DOI
- 10.1083/jcb.119.2.249 · DOI
- 10.1016/S0021-9258(18)41900-X · DOI · Paper page
- 10.1002/cne.902100303 · DOI
- Kitabgi P, 1985, Pharmacology and biochemistry of neurotensin receptors, Rev Clin Basic Pharm, 5, 397
- Kitabgi P, 1992, The neurobiology of neurotensin, Ann NY Acad Sci, 668, 1
- 10.1016/0014-2999(87)90285-8 · DOI
- Labbé‐Jullié C, 1994, In vivo and in vitro structure‐activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes, J Pharmacol Exp Ther, 268, 328
- 10.1016/0306-4522(96)00210-2 · DOI
- 10.1016/S0165-3806(99)00009-7 · DOI
- 10.1074/jbc.272.39.24145 · DOI
- 10.1016/0092-8674(94)90219-4 · DOI · Paper page
- 10.1053/gast.2002.36000 · DOI
- Martin S, Involvement of the neurotensin receptor‐3 in the neurotensin‐induced migration of human microglia, J Neurosci, 23, 1198, 10.1523/JNEUROSCI.23-04-01198.2003 · DOI
- 10.1016/S0898-6568(00)00130-3 · DOI
- Mazella J, 1989, Purification of the neurotensin receptor from mouse brain by affinity chromatography, J Biol Chem, 264, 5559, 10.1016/S0021-9258(18)83582-7 · DOI
- 10.1074/jbc.273.41.26273 · DOI
- 10.1074/jbc.273.6.3582 · DOI · Paper page
- 10.1016/0306-4522(87)90350-2 · DOI
- 10.1016/S0014-5793(01)02367-5 · DOI
- 10.1074/jbc.274.13.8832 · DOI · Paper page
- 10.1016/S0306-4522(99)00354-1 · DOI
- 10.1038/294587a0 · DOI
- 10.1126/science.283.5400.401 · DOI
- 10.1074/jbc.272.6.3599 · DOI · Paper page
- 10.1093/emboj/18.3.595 · DOI
- 10.1016/S0925-4773(00)00523-2 · DOI
- 10.1006/frne.1996.0146 · DOI
- Sarret P, 2002, Peptide receptors, Part II, 323, 10.1016/S0924-8196(02)80008-2 · DOI
- 10.1002/(SICI)1096-9861(19980511)394:3<344::AID-CNE6>3.0.CO;2-1 · DOI
- Sarret P, 2002, Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells, J Biol Chem, 25, 36233, 10.1074/jbc.M202586200 · DOI
- 10.1016/0306-4522(92)90344-2 · DOI
- 10.1016/0006-8993(87)90398-2 · DOI
- 10.1007/BF00500016 · DOI
- 10.1111/j.1471-4159.1988.tb10568.x · DOI
- 10.1210/en.141.1.354 · DOI
- 10.1016/0304-3940(87)90214-X · DOI
- 10.1002/cne.902790111 · DOI
- 10.1111/j.1749-6632.1982.tb31565.x · DOI
- Vandenbulcke F, 2000, Ligand‐induced internalization of neurotensin in transfected COS‐7 cells: differential intracellular trafficking of ligand and receptor, J Cell Sci, 113, 2963, 10.1242/jcs.113.17.2963 · DOI
- 10.1016/0006-8993(90)91258-I · DOI
- 10.1016/S0306-4522(98)00763-5 · DOI
- 10.1097/00001756-200011090-00009 · DOI
- 10.1002/1096-9861(20000828)424:3<461::AID-CNE5>3.0.CO;2-J · DOI
- 10.1016/S0165-6147(99)01357-7 · DOI
- 10.1016/S0169-328X(98)00074-6 · DOI
- 10.1016/0306-4522(94)90212-7 · DOI
- 10.5551/jat1994.4.20 · DOI
Cited by
Sorted by citations
Sortilin is essential for proNGF-induced neuronal cell death
Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., Jacobsen, C., Kliemannel, M., Schwarz, E., Willnow, T. E., et al. (2004) · Nature · doi:10.1038/nature02319 · Cited by 962
Self-citationNeurotrophins and Proneurotrophins: Focus on Synaptic Activity and Plasticity in the Brain
Gibon, J., & Barker, P. A. (2017) · The Neuroscientist · doi:10.1177/1073858417697037 · Cited by 115
Carlo, A.-S., Gustafsen, C., Mastrobuoni, G., Nielsen, M. S., Burgert, T., Hartl, D., Rohe, M., Nykjaer, A., Herz, J., Heeren, J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2425-12.2013 · Cited by 117
Self-citationLee, M. R., Hinton, D. J., Unal, S. S., Richelson, E., & Choi, D.-S. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01326.x · Cited by 32
Greda, A. K., Gomes, J. P., Schmidt-Krueger, V., Zurawska-Plaksej, E., Fritsche-Guenther, R., Rudolph, I.-M., Telugu, N. S., Cömert, C., Kirwan, J., Kunz, S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01389-5 · Cited by 21
Metadata
- Authors
- Sarret, P., Krzywkowski, P., Segal, L., Nielsen, M. S., Petersen, C. M., Mazella, J., Stroh, T., & Beaudet, A.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2003-05-08
- Volume
- 461
- Issue
- 4
- Pages
- 483-505
- ISSN
- 0021-9967
- 1096-9861
- Cited by
- 132
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review